The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126247961 12624796 1 I 20160510 20160726 20160805 20160805 EXP PHHY2016CN104488 NOVARTIS 44.99 YR M Y 0.00000 20160805 MD CN CN

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126247961 12624796 1 SS MYFORTIC MYCOPHENOLATE SODIUM 1 Oral 1440 MG, QD Y 0 1440 MG QD
126247961 12624796 2 SS MYFORTIC MYCOPHENOLATE SODIUM 1 Oral 1260 MG, QD Y 0 1260 MG QD
126247961 12624796 3 SS MYFORTIC MYCOPHENOLATE SODIUM 1 Oral 900 MG, QD Y 0 900 MG QD
126247961 12624796 4 SS MYFORTIC MYCOPHENOLATE SODIUM 1 Oral 720 MG, QD Y 0 720 MG QD
126247961 12624796 5 PS BASILIXIMAB BASILIXIMAB 1 Unknown 20 MG, QD Y 103764 20 MG SOLUTION FOR INJECTION QD
126247961 12624796 6 SS BASILIXIMAB BASILIXIMAB 1 Y 103764 SOLUTION FOR INJECTION
126247961 12624796 7 SS TACROLIMUS. TACROLIMUS 1 Unknown 5.5 MG, QD 0 5.5 MG CAPSULE QD
126247961 12624796 8 SS TACROLIMUS. TACROLIMUS 1 Unknown 6 MG, QD 0 6 MG CAPSULE QD
126247961 12624796 9 SS TACROLIMUS. TACROLIMUS 1 Unknown 4.5 MG, QD 0 4.5 MG CAPSULE QD
126247961 12624796 10 SS TACROLIMUS. TACROLIMUS 1 Unknown 3.5 MG, QD 0 3.5 MG CAPSULE QD
126247961 12624796 11 SS MYCOPHENOLATE MOFETIL. MYCOPHENOLATE MOFETIL 1 Unknown 1000 MG, QD 1000 MG Y 0 1000 MG QD
126247961 12624796 12 SS MYCOPHENOLATE MOFETIL. MYCOPHENOLATE MOFETIL 1 1000 MG Y 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126247961 12624796 1 Renal transplant
126247961 12624796 5 Renal transplant
126247961 12624796 6 Immunosuppressant drug therapy
126247961 12624796 7 Renal transplant
126247961 12624796 8 Immunosuppressant drug therapy
126247961 12624796 11 Renal transplant
126247961 12624796 12 Immunosuppressant drug therapy

Outcome of event

Event ID CASEID OUTC COD
126247961 12624796 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
126247961 12624796 Abdominal pain upper
126247961 12624796 Alanine aminotransferase increased
126247961 12624796 Aspartate aminotransferase increased
126247961 12624796 Blood creatinine increased
126247961 12624796 Blood glucose increased
126247961 12624796 Blood triglycerides increased
126247961 12624796 Blood urea increased
126247961 12624796 Haemoglobin decreased
126247961 12624796 High density lipoprotein decreased
126247961 12624796 Lymphocyte count decreased
126247961 12624796 Neutrophil count increased
126247961 12624796 Platelet count decreased
126247961 12624796 Urine analysis abnormal
126247961 12624796 White blood cell count decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126247961 12624796 1 20160510 20160510 0
126247961 12624796 2 20160511 20160601 0
126247961 12624796 3 20160530 20160601 0
126247961 12624796 4 20160602 0
126247961 12624796 5 20160510 20160510 0
126247961 12624796 7 20160510 20160524 0
126247961 12624796 8 20160525 20160526 0
126247961 12624796 9 20160527 20160531 0
126247961 12624796 10 20160603 0
126247961 12624796 11 20160509 20160509 0